Psychosis Risk
Study register · detail Meta-Analyse (Querschnittsstudien) · Psychosis Risk · 2014

Association between cannabis use and schizotypal dimensions--a meta-analysis of cross-sectional studies.

Clear benefit GRADE High 52 citations
Samplek = 29 Studien
ControlNo cannabis use
EndpointSchizotypy score
Blindingn.a.
DesignMeta-Analyse (Querschnittsstudien)
Key finding

Cannabis use is consistently associated with increased schizotypy scores, with small to medium effect sizes.

Summary

Meta-analysis of k=29 cross-sectional studies; cannabis use vs. never use: increased schizotypy scores for all 4 dimensions (total, positive, negative, disorganised), effect sizes in the small to medium range, statistically significant (except negative score for current vs. other); cannabis use consistently associated with increased subclinical psychosis traits.

P
PopulationGeneral population/non-clinical samples – persons with and without cannabis use; pooled from 29 cross-sectional studies
I
InterventionCannabis use (at least once or current use)
C
ControlNo cannabis use (never used or no current use)
O
OutcomeIn all 8 comparisons, cannabis users had higher schizotypy scores (small to medium effect sizes); with the exception of the negative score comparison (current vs. other) all differences were statistically significant
Confidence in the evidence
High

The highest of four GRADE levels, the effect estimate is very reliable.

Quality profile
Sample size
Blinding
Effect size Clear benefit
Citations / year
Authors
Szoke A, Galliot AM, Richard JR, Ferchiou A, Baudin G, Leboyer M, Schürhoff F.
DOI 10.1016/j.psychres.2014.05.008
Design: Meta-Analyse (Querschnittsstudien)
Share
Abstract
Cannabis consumption can cause abuse and dependence and increase risk of developing psychiatric and somatic disorders. Several literature reviews explored the link between cannabis consumption and schizophrenia but none summarized the rich literature on cannabis and psychometric schizotypy. The aim of our review is to synthesize data from studies that explored the association between cannabis consumption and schizoptypal dimensions. A systematic review of the literature and, when needed, contact with the authors, allowed us to gather data from 29 cross-sectional studies. We compared schizotypy scores between subjects that never used cannabis and subjects that used it at least once ("never vs. ever") and between current users and subjects that do not use cannabis currently ("current vs. other"). We conducted separate analyses for total schizotypy score and each of the three classical schizotypal dimensions (positive, negative, disorganized). For all eight comparisons, the cannabis group ("ever" or "current") had higher schizotypy scores. Differences were in the small or medium range and, with the exception of the negative score in the current vs. other comparison, statistically significant. Cannabis consumption is associated with increased schizotypal traits. More research, using different approaches (e.g. longitudinal studies) is needed to explore the cause of this association.

The impediment to action advances action. — Marcus Aurelius